Протокол «Надання медичної допомоги для лікування коронавірусної хвороби (COVID-19)»

Анотація

Протокол «Надання медичної допомоги для лікування коронавірусної хвороби (COVID-19)»

pdf

Посилання

1. World Health Organization (WHO). Off-label use of medicines for COVID-19, 31.03.2020. https://www.who.int/news-room/commentaries/detail/off-label-use-ofmedicines-for-COVID-19
2. World Health Organization (WHO). Clinical management of COVID-19, 27.05.2020. https://www.who.int/publications-detail/clinical-management-of-COVID-19
3. World Health Organization (WHO). COVID-19 Clinical management: living guidance, 25.01.2021. https://www.who.int/publications/i/item/WHO-2019nCoVclinical-2021-1
4. World Health Organization (WHO). Living guidance «Corticosteroids for COVID-19», 02.09.2020. https://www.who.int/publications/i/item/WHO-2019-nCoVCorticosteroids-2020.1
5. World Health Organization (WHO). Living guidance «Therapeutics and COVID-19: living guideline», 17.12.2020. https://www.who.int/publications/i/item/
therapeutics-and-COVID-19-living-guideline
6. Всесвітня організація охорони здоров’я (ВООЗ). Клінічна допомога при важкій гострій респіраторній інфекції: інструментарій. Адаптовано до
COVID-19. https://apps.who.int/iris/bitstream/handle/10665/333001/WHO-2019-nCoV-SARI-toolkit-2020.1-ukr.pdf?sequence=1&isAllowed=y
7. World Health Organization (WHO). Tackling antimicrobial resistance in the COVID-19 pandemic https://www.who.int/bulletin/volumes/98/7/20-268573/
en/#:~:text=The%20guidance%20does%20not%20recommend,of%20a%20bacterial %20infection%20exist.
8. European Medicines Agency (EMA) provides recommendations on compassionate use of remdesivir for COVID-19, 03.04.2020. https://www.ema.europa.eu/en/
news/ema-provides-recommendations-compassionate-use-remdesivir-COVID-19
9. European Medicines Agency (EMA) Summary on compassionate use Remdesivir, 03.04.2020. https://www.ema.europa.eu/en/documents/other/summarycompassionate-use-remdesivir-gilead_en.pdf
10. EMA recommends expanding remdesivir compassionate use to patients not on mechanical ventilation, 11.05.2020. https://www.ema.europa.eu/en/news/emarecommends-expanding-remdesivir-compassionate-use-patients-not-mechanical-ventilation
11. European Medicines Agency (EMA). First COVID-19 treatment Remdesivir recommended for EU authorisation, 25.06.2020. https://www.ema.europa.eu/en/
news/first-COVID-19-treatment-recommended-eu-authorisation
12. European Medicines Agency (EMA). Summary of product characteristics of Veklury (remdesivir) https://www.ema.europa.eu/en/medicines/human/EPAR/veklury
13. European Medicines Agency (EMA) EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic, 06.04.2020: https://www.ema.europa.eu/en/news/eu-authorities-agree-new-measures-support-availability-medicines-used-COVID-19-pandemic
14. European Medicines Agency (EMA) Compassionate use https://www.ema.europa.eu/en/human-regulatory/research-development/compassionate-use
15. U.S. Food and Drug Administration (FDA). FDA issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment of
suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease, 01.05.2020. https://www.fda.gov/media/137564/download

Завантаження

Дані завантаження ще не доступні.